Small Molecules for Precision Medicine

Learn More about Arqule

We are pursuing multiple programs in biomarker-defined oncology and rare disease indications

Targeted Approach to Cancer

Clinical Trials

Research & Development

Product Pipeline

Targeted Approach To

Rare Diseases

News & Events

September 29, 2017

Proteus Syndrome Phase 1 Data Presentation

ArQule to Participate in the BTIG Biotechnology Conference on Monday, August 12, 2019

ArQule Reports Second Quarter 2019 Financial Results

More News & Events »